ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2652

Abnormal Expression of Long Noncoding RNA Lncrna-CMPK2 Facilitates Neutrophils Interferon Production By TLR7/8 Agonist Stimulation in SLE

Zhixin Xue, Yuanjia Tang and Nan Shen, Shanghai Institute of Rheumatology,Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: interferons and neutrophils, SLE

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Interferon plays prominent role in systemic lupus erythematosus (SLE) pathogenesis while the source of high interferon in SLE is still confused, several cell types can produce interferon, neutrophils as one of important interferon source cells have been arousing growing attention, however the interferon production capacity of neutrophils in SLE and the regulation of neutrophils interferon production still remain unclear. Many long noncoding RNAs (lncRNAs) have been identified abnormally expressed in SLE that act on multiple signal pathways, we presume that there could be a role of lncRNAs in neutrophils interferon production regulation.

Methods: Interferon production was measured by qPCR and ISRE reporter gene assay, neutrophils interferon production capacity enhanced after interferon prime. We aimed to find out LncRNA that work in it. RNA-seq was performed in two sets of samples, interferon stimulated neutrophils samples and SLE versus healthy controls neutrophils samples. LncRNA-CMPK2 was screened out by cross-reference the two RNA-seq results. Expression of lncRNA-CMPK2 was knocked down in primary neutrophils using antisense oligos (ASO) by electroporation. To dissect the mechanism that lncRNA-CMPK2 act on TLR7/8 pathway interferon production, western blot was conducted to measure expression of key molecules in this pathway.

Results: 1. Neutrophils from SLE patients produced two fold more interferon than that from healthy controls by TLR7/8 agonist R848 stimulation. 2. Neutrophils interferon production capacity enhanced after interferon prime. 3. LncRNA-CMPK2 highly expressed in SLE neutrophils, it was the top 2 differently expressed lncRNA in lupus versus healthy controls and was also among the top significantly interferon stimulated lncRNAs according to the two sets of RNA-seq profiling. 4. LncRNA-CMPK2 expression level correlated with lupus interferon score and disease activity. 5. Knockdown of LncRNA-CMPK2 in neutrophils can attenuate interferon production. The mechanism may rely on reducing expression of IRAK4 and IRF7.

Conclusion: LncRNA-CMPK2 facilitates neutrophils interferon production in lupus. Over expression status of lncRNA-CMPK2 may provide new understanding of high interferon in the disease, targeting lncRNA-CMPK2 could probably help to control high interferon level in lupus.


Disclosure: Z. Xue, None; Y. Tang, None; N. Shen, None.

To cite this abstract in AMA style:

Xue Z, Tang Y, Shen N. Abnormal Expression of Long Noncoding RNA Lncrna-CMPK2 Facilitates Neutrophils Interferon Production By TLR7/8 Agonist Stimulation in SLE [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/abnormal-expression-of-long-noncoding-rna-lncrna-cmpk2-facilitates-neutrophils-interferon-production-by-tlr78-agonist-stimulation-in-sle/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/abnormal-expression-of-long-noncoding-rna-lncrna-cmpk2-facilitates-neutrophils-interferon-production-by-tlr78-agonist-stimulation-in-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology